CLINICAL INNOVATION ApS: Financial statements 2024
CVR: 29924880
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
CLINICAL INNOVATION ApS (CVR 29924880) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,216,934 and a net result of DKK 95,746 compared with DKK -7,404 the year before. That is a decrease of 4% compared with the year before. Equity in the 2024 report amounted to DKK 3,758,115. The solvency ratio was 39%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,216,934
- Profit/Loss
- DKK 95,746
- Equity
- DKK 3,758,115
- Total Assets
- DKK 9,632,323
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2.2M | 96K | 3.8M | 2 |
| 2023 | - | 2.3M | -7K | 3.7M | 3 |
| 2022 | - | 3.4M | 41K | 3.7M | 8 |
| 2021 | - | 4M | 562K | 3.6M | 8 |
| 2020 | - | 3.9M | 593K | 3.6M | 7 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
CLINICAL INNOVATION ApS has published its annual report for 2023. Gross profit came to DKK 2,310,350, and the net result was DKK -7,404.
As of April 19, 2024, inforevision statsautoriseret revisionsaktieselskab has been appointed auditor of CLINICAL INNOVATION ApS.
As of April 19, 2024, AAEN & CO. STATSAUTORISEREDE REVISORER P/S has stepped down as auditor of CLINICAL INNOVATION ApS.
About CLINICAL INNOVATION ApS
CLINICAL INNOVATION ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Claus Michael Dinesen. The board consists of Ole Hedemann (chair), Claus Michael Dinesen, Magnus Oliver Lundegård Pacheco Dinesen and Marc Phillip Gall Schultz Lorentzen. The company is owned by PIA & CLAUS DINESEN HOLDING ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 2,775,826 and a net result of DKK 413,835 compared with DKK 95,746 the year before. Equity in the 2025 report amounted to DKK 3,821,950.